 |
인쇄하기
취소
|
SK, Janssen Korea to co-market Mvix
SK Chemicals and Janssen Korea has recently announced that the two companies signed an agreement to co-market Mvix, a new impotence drug, here from the latter half of next year.
MVIX is the 13th new drug developed by the Korean company. SK spent 15 billion won on creating the drug in partnership with bio venture firm IN2GEN.
Emphasizing the important synergy created by this partnership, L...
MVIX is the 13th new drug developed by the Korean company. SK spent 15 billion won on creating the drug in partnership with bio venture firm IN2GEN.
Emphasizing the important synergy created by this partnership, L...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.